The abstract is read at the publisher; the summary is JClub's.
Tn antigen expression on pancreatic ductal adenocarcinoma cells enhances tumor growth in vivo and drives IL-34–linked immune remodeling.
- Why it matters: Early Tn-targeted therapies have lacked clear signals, and the field needs mechanisms explaining how truncated O-glycans both promote PDAC progression and reshape immunosuppression.
- What they did: The study tested Tn effects in vitro and in vivo, used single-cell RNA sequencing to profile infiltrating immune cells, and combined tumor transcriptomics with Il34 deletion and IL-34 supplementation.
- The result: Tn+ tumors showed M2-like macrophage skewing, reduced cross-presenting dendritic cells, and expanded MDSCs with antigen-presentation downregulation; Il34 loss attenuated Tn-driven tumorigenesis and MDSC infiltration, while recombinant IL-34 promoted myeloid differentiation and proliferation in vitro.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.